Cargando…
Cognitive symptoms after COVID-19
INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially crit...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669718/ http://dx.doi.org/10.1016/j.neurop.2021.10.005 |
_version_ | 1784614834950635520 |
---|---|
author | Altuna, M. Sánchez-Saudinós, Mª.B. Lleó, A. |
author_facet | Altuna, M. Sánchez-Saudinós, Mª.B. Lleó, A. |
author_sort | Altuna, M. |
collection | PubMed |
description | INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially critically ill patients, are at greater risk of developing cognitive symptoms. Post–COVID-19 cognitive symptoms, unlike those associated with other viral illnesses, have been observed in patients with mild infection, and present some atypical features. Cognitive symptoms may last longer in COVID-19 than in other infectious processes, and more frequently affect young people. Post–COVID-19 cognitive symptoms share common features with those described in chronic fatigue syndrome, including a similar profile with affective symptoms. Brief screening tests for cognitive impairment present suboptimal diagnostic performance, and standardised criteria are needed to ensure correct diagnosis. Post–COVID-19 cognitive impairment can have a significant impact on the patient's quality of life and functional independence, regardless of other post–COVID-19 symptoms. Currently, no specific treatments have been approved for post–COVID-19 cognitive impairment, although cognitive stimulation may be useful in some patients. CONCLUSIONS: Post–COVID-19 cognitive symptoms are common and are often associated with other systemic symptoms. Neuropsychological evaluation may be useful for diagnosis and to quantify their severity and long-term prognosis. Detailed, and individualised assessment of cognitive impairment may enable the design of treatment plans. |
format | Online Article Text |
id | pubmed-8669718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedad Española de Neurología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86697182021-12-14 Cognitive symptoms after COVID-19 Altuna, M. Sánchez-Saudinós, Mª.B. Lleó, A. Neurology Perspectives Review INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially critically ill patients, are at greater risk of developing cognitive symptoms. Post–COVID-19 cognitive symptoms, unlike those associated with other viral illnesses, have been observed in patients with mild infection, and present some atypical features. Cognitive symptoms may last longer in COVID-19 than in other infectious processes, and more frequently affect young people. Post–COVID-19 cognitive symptoms share common features with those described in chronic fatigue syndrome, including a similar profile with affective symptoms. Brief screening tests for cognitive impairment present suboptimal diagnostic performance, and standardised criteria are needed to ensure correct diagnosis. Post–COVID-19 cognitive impairment can have a significant impact on the patient's quality of life and functional independence, regardless of other post–COVID-19 symptoms. Currently, no specific treatments have been approved for post–COVID-19 cognitive impairment, although cognitive stimulation may be useful in some patients. CONCLUSIONS: Post–COVID-19 cognitive symptoms are common and are often associated with other systemic symptoms. Neuropsychological evaluation may be useful for diagnosis and to quantify their severity and long-term prognosis. Detailed, and individualised assessment of cognitive impairment may enable the design of treatment plans. Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021-12 2021-12-14 /pmc/articles/PMC8669718/ http://dx.doi.org/10.1016/j.neurop.2021.10.005 Text en © 2021 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Altuna, M. Sánchez-Saudinós, Mª.B. Lleó, A. Cognitive symptoms after COVID-19 |
title | Cognitive symptoms after COVID-19 |
title_full | Cognitive symptoms after COVID-19 |
title_fullStr | Cognitive symptoms after COVID-19 |
title_full_unstemmed | Cognitive symptoms after COVID-19 |
title_short | Cognitive symptoms after COVID-19 |
title_sort | cognitive symptoms after covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669718/ http://dx.doi.org/10.1016/j.neurop.2021.10.005 |
work_keys_str_mv | AT altunam cognitivesymptomsaftercovid19 AT sanchezsaudinosmab cognitivesymptomsaftercovid19 AT lleoa cognitivesymptomsaftercovid19 |